Omega Healthcare Investors, Inc. (OHI)
NYSE: OHI · IEX Real-Time Price · USD
32.33
+0.79 (2.50%)
May 31, 2024, 4:00 PM EDT - Market closed
OHI Stock Forecast
Stock Price Forecast
The 12 analysts with 12-month price forecasts for OHI stock have an average target of 33.79, with a low estimate of 30 and a high estimate of 36. The average target predicts an increase of 4.52% from the current stock price of 32.33.
Analyst Consensus: Buy
* Price targets were last updated on Apr 2, 2024.
Analyst Ratings
The average analyst rating for OHI stock from 13 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 5 | 5 | 4 |
| Buy | 1 | 1 | 2 | 2 | 2 | 2 |
| Hold | 7 | 7 | 6 | 6 | 6 | 7 |
| Sell | 2 | 1 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 14 | 13 | 12 | 13 | 13 | 13 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JMP Securities | JMP Securities | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | May 6, 2024 |
| Truist Securities | Truist Securities | Hold Maintains $31 → $32 | Hold | Maintains | $31 → $32 | -1.02% | Apr 2, 2024 |
| Citigroup | Citigroup | Hold → Strong Buy Upgrades $32 → $35 | Hold → Strong Buy | Upgrades | $32 → $35 | +8.26% | Mar 22, 2024 |
| Wells Fargo | Wells Fargo | Hold → Buy Upgrades $31 → $35 | Hold → Buy | Upgrades | $31 → $35 | +8.26% | Feb 26, 2024 |
| Exane BNP Paribas | Exane BNP Paribas | Sell → Hold Upgrades $30 | Sell → Hold | Upgrades | $30 | -7.21% | Feb 8, 2024 |
Financial Forecast
Revenue This Year
1.00B
from 949.74M
Increased by 5.40%
Revenue Next Year
1.09B
from 1.00B
Increased by 8.59%
EPS This Year
1.36
from 1.00
Increased by 35.68%
EPS Next Year
1.53
from 1.36
Increased by 12.66%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 1.0B | 1.2B | 1.2B | 900.4M | 909.1M |
| Avg | 1.0B | 1.1B | 1.0B | 866.1M | 874.5M |
| Low | 971.0M | 1.0B | 883.9M | 840.4M | 848.5M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 9.6% | 17.5% | 12.4% | -13.7% | 5.0% |
| Avg | 5.4% | 8.6% | -4.0% | -17.0% | 1.0% |
| Low | 2.2% | 1.0% | -18.7% | -19.4% | -2.0% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 1.52 | 1.72 | 1.60 | 3.30 |
| Avg | 1.36 | 1.53 | 1.54 | 3.17 |
| Low | 1.24 | 1.38 | 1.49 | 3.08 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 52.3% | 26.9% | 4.4% | 114.8% |
| Avg | 35.7% | 12.7% | 0.4% | 106.6% |
| Low | 24.5% | 1.8% | -2.5% | 100.4% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.